Press Release: CSSi : CSSi's MyClinicalTrial ID Database Exceeds 1 Million Patients

CSSi, a global full-service patient recruitment company, today announced that its MyClinicalTrial ID (MCT ID) database has expanded to over one million patients. MCT ID was developed to improve the investigator site selection and patient recruitment processes in a confidential and HIPAA-compliant manner. This increases study success by guaranteeing that only sites with patients who meet the study criteria will be selected to participate as investigative sites.